Levee Medical Secures $14M Series B to Revolutionize Post-Prostatectomy Recovery Outcomes

Levee Medical, Inc., a trailblazer in the development of innovative urological devices, is thrilled to announce that it has raised $14,000,000 in its latest funding round. This significant infusion of capital will accelerate the company’s mission to improve recovery outcomes for patients undergoing prostatectomy by expediting their return to normal daily activities. By focusing on advanced medical device engineering, Levee Medical, Inc. has dedicated its efforts to designing and manufacturing state-of-the-art solutions that provide critical support during the delicate post-operative period. The company's inaugural product, a groundbreaking device, is engineered to support and stabilize the post-operative bladder neck and urethra, thereby accelerating the return of continence and mitigating the risk of chronic incontinence—a condition that can severely impact quality of life. The recent funding will be pivotal in expanding research and development initiatives, streamlining manufacturing processes, and broadening the company’s reach to healthcare professionals and patients nationwide. In addition, a portion of the funds will be allocated to comprehensive clinical studies and trials, ensuring that the product not only meets but exceeds the rigorous standards of modern medical practice. This strategic investment reflects a strong vote of confidence from investors who recognize the potential of Levee Medical’s innovative approach in transforming post-prostatectomy recovery. As the company continues to push the boundaries of medical engineering and patient care, the new capital will help it advance its vision of empowering patients to regain their confidence and return to everyday activities with greater speed and improved long-term health outcomes.